ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) | ||
Securities registered pursuant to Section 12(b) of the Act: | ||
Title of each class | Trading Symbol | Name of each exchange on which registered |
NYSE Texas | ||
Securities registered pursuant to Section 12(g) of the Act: None | ||
☒ | Accelerated Filer | ☐ | ||
Non-accelerated Filer | ☐ | Smaller Reporting Company | ||
Emerging Growth Company |
PART I | PAGE | |
PART II | ||
PART III | ||
PART IV | ||
Item 1 | Business |
Item 1 | Business |
Item 1 | Business |




Item 1 | Business |
Item 1 | Business |
Item 1 | Business |
Item 1 | Business |
Name and Age | Offices Held and Term of Office | |
Van H. Beckwith (Age 60) | Executive Vice President, Secretary, and Chief Legal Officer, since December 2020 | |
Eric J. Carre (Age 59) | Executive Vice President and Chief Financial Officer, since May 2022 | |
Executive Vice President, Global Business Lines, May 2016 to April 2022 | ||
Stephanie S. Holzhauser (Age 46) | Senior Vice President and Chief Accounting Officer, since July 2025 | |
Vice President, Finance, September 2021 to July 2025 | ||
Senior Director, Global Business Lines, October 2014 to August 2021 | ||
Timothy M. McKeon (Age 53) | Senior Vice President and Treasurer, since January 2022 | |
Vice President and Treasurer, January 2014 to December 2021 | ||
Jeffrey A. Miller (Age 62) | Chairman of the Board, President, and Chief Executive Officer, since January 2019 | |
Lawrence J. Pope (Age 57) | Executive Vice President and Chief Administrative Officer, since January 2026 | |
Executive Vice President of Administration and Chief Human Resources Officer, January 2008 to December 2025 | ||
M. Casey Maxwell (Age 44) | President, Western Hemisphere, since February 2026 | |
Senior Vice President, North America Land, July 2024 to January 2026 | ||
Vice President, Argentina, July 2023 to June 2024 | ||
Vice President, Permian Basin, January 2019 to June 2023 | ||
Jill D. Sharp (Age 55) | Senior Vice President, Internal Assurance Services, since January 2022 | |
Vice President, Internal Assurance Services, September 2021 to December 2021 | ||
Vice President, Finance - Western Hemisphere, October 2016 to August 2021 | ||
J. Shannon Slocum (Age 53) | Director, Executive Vice President and Chief Operating Officer, since January 2026 | |
President, Eastern Hemisphere, March 2023 to December 2025 | ||
Senior Vice President, Global Business Development and Marketing, January 2020 to February 2023 | ||
Rami M. Yassine (Age 46) | President, Eastern Hemisphere, since January 2026 | |
Senior Vice President, Middle East and North Africa, May 2024 to December 2025 | ||
Senior Vice President, Drilling and Evaluation, January 2022 to April 2024 | ||
Vice President, Sperry Drilling, January 2021 to December 2021 |
Item 1 | Business |
Name | Title and company | |
Abdulaziz F. Al Khayyal | Former Director and Senior Vice President of Industrial Relations, Saudi Aramco | |
William E. Albrecht | President and CEO, Moncrief Energy, LLC | |
M. Katherine Banks | Former President, Texas A&M University | |
Alan M. Bennett | Former President and Chief Executive Officer, H&R Block, Inc. | |
Earl M. Cummings | Managing Partner, MCM Houston Properties, LLC | |
Murry S. Gerber | Former Executive Chairman of the Board, EQT Corporation | |
Timothy A. Leach | Former Advisor to the Chief Executive Officer, ConocoPhillips | |
Robert A. Malone | Executive Chairman, President and Chief Executive Officer, First Sonora Bancshares, and The First National Bank of Sonora, Texas (dba, Sonora Bank). | |
Jefferey A. Miller | Chairman of the Board, President and Chief Executive Officer, Halliburton Company | |
J. Shannon Slocum | Director, Executive Vice President and Chief Operating Officer, Halliburton Company | |
Maurice S. Smith | Chairman, President & Chief Executive Officer, Health Care Service Corporation | |
Janet L. Weiss | Former President, BP Alaska | |
Tobi M. Edwards Young | General Counsel, Saronic Technologies | |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(a) | Risk Factors |
Item 1(b) | Unresolved Staff Comments |
Item 2 | Properties |
Item 5 | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |

December 31, | |||||||
2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
Halliburton | $100.00 | $121.99 | $212.88 | $199.13 | $152.98 | $163.76 | |
Philadelphia Oil Service Index (OSX) | 100.00 | 120.74 | 194.98 | 198.71 | 175.53 | 181.72 | |
Standard & Poor’s 500 ® Index | 100.00 | 128.71 | 105.40 | 133.10 | 166.40 | 196.16 | |
Item 5 | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
Period | Total Number of Shares Purchased (a) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b) | Maximum Number (or Approximate Dollar Value) of Shares that may yet be Purchased Under the Program (b) |
October 1 - 31 | 4,056,882 | $24.37 | 4,000,984 | $2,201,987,042 |
November 1 - 30 | 2,747,338 | $26.82 | 2,724,670 | $2,128,889,195 |
December 1 - 31 | 2,899,614 | $28.08 | 2,836,385 | $2,049,168,144 |
Total | 9,703,834 | $26.17 | 9,562,039 |
(a) | Of the 9,703,834 shares purchased during the three-month period ended December 31, 2025, 141,795 were acquired from employees in connection with the settlement of income tax and related benefit withholding obligations arising from vesting in restricted stock grants. These shares were not part of a publicly announced program to purchase common stock. |
(b) | Our Board of Directors has authorized a program to repurchase a specified dollar amount of our common stock from time to time. On July 21, 2014, our Board of Directors announced that it had approved an increase in the total available outstanding authorization for repurchases to $6.0 billion. Approximately $2.0 billion remained authorized for repurchases as of December 31, 2025. From the inception of this program in February 2006 through December 31, 2025, we repurchased approximately 326 million shares of our common stock for a total cost of approximately $12.1 billion. The program may be terminated or suspended at any time and does not have a specified expiration date. |
Item 7 | Executive Overview |

Item 7 | Executive Overview |
Item 7 | Liquidity and Capital Resources |
Item 7 | Liquidity and Capital Resources |
Item 7 | Business Environment and Results of Operations |
2025 | 2024 | 2023 | |
Oil Price - WTI (1) | $65.46 | $76.55 | $77.64 |
Oil Price - Brent (1) | 69.10 | 80.53 | 82.47 |
Natural Gas Price - Henry Hub (2) | 3.53 | 2.19 | 2.54 |
(1) | Oil prices measured in dollars per barrel. | ||||
(2) | Natural gas price measured in dollars per million British thermal units (Btu), or MMBtu. | ||||
2025 | 2024 | 2023 | |
US Land | 546 | 580 | 669 |
US Offshore | 15 | 19 | 18 |
Canada | 175 | 187 | 177 |
North America | 736 | 786 | 864 |
International (1) | 1,080 | 1,162 | 948 |
Worldwide Total | 1,816 | 1,948 | 1,812 |
(1) | Historical average rig counts shown are based on data provided by Baker Hughes, which included retroactive adjustments to international rig counts previously reported as a result of a methodology change effective January 2024. | ||||
Item 7 | Business Environment and Results of Operations |
Item 7 | Results of Operations in 2025 Compared to 2024 |
Favorable | Percentage | |||
Millions of dollars | 2025 | 2024 | (Unfavorable) | Change |
Revenue: | ||||
By operating segment: | ||||
Completion and Production | $12,782 | $13,251 | $(469) | (4)% |
Drilling and Evaluation | 9,402 | 9,693 | (291) | (3) |
Total revenue | $22,184 | $22,944 | $(760) | (3)% |
By geographic region: | ||||
North America | $9,066 | $9,626 | $(560) | (6)% |
Latin America | 3,935 | 4,211 | (276) | (7) |
Europe/Africa/CIS | 3,351 | 3,003 | 348 | 12 |
Middle East/Asia | 5,832 | 6,104 | (272) | (4) |
Total revenue | $22,184 | $22,944 | $(760) | (3)% |
Operating income: | ||||
By operating segment: | ||||
Completion and Production | $2,128 | $2,709 | $(581) | (21)% |
Drilling and Evaluation | 1,379 | 1,608 | (229) | (14) |
Total operations | 3,507 | 4,317 | (810) | (19) |
Corporate and other | (262) | (255) | (7) | (3) |
SAP S4 upgrade expense | (154) | (124) | (30) | (24) |
Impairments and other charges | (831) | (116) | (715) | n/m |
Total operating income | $2,260 | $3,822 | $(1,562) | (41)% |
n/m = not meaningful | ||||
Item 7 | Results of Operations in 2025 Compared to 2024 |
Item 7 | Results of Operations in 2025 Compared to 2024 |
Item 7 | Results of Operations in 2024 Compared to 2023 |
Item 7 | Critical Accounting Estimates |
Item 7 | Critical Accounting Estimates |
Item 7 | Critical Accounting Estimates |
Item 7 | Financial Instrument Market Risk |
Item 7 | Environmental Matters |
Item 7(a) | Quantitative and Qualitative Disclosures About Market Risk |
Financial Statements | PAGE |
Notes to Consolidated Financial Statements | |
/s/ Jeffrey A. Miller | /s/ Eric J. Carre | |
Jeffrey A. Miller | Eric J. Carre | |
Chairman of the Board, President and | Executive Vice President and | |
Chief Executive Officer | Chief Financial Officer |
Year Ended December 31, | |||
Millions of dollars and shares except per share data | 2025 | 2024 | 2023 |
Revenue: | |||
Services | $ | $ | $ |
Product sales | |||
Total revenue | |||
Operating costs and expenses: | |||
Cost of services | |||
Cost of sales | |||
Impairments and other charges | |||
General and administrative | |||
SAP S4 upgrade expense | |||
Total operating costs and expenses | |||
Operating income | |||
Interest expense, net of interest income of $88, $97, and $81 | ( | ( | ( |
Argentina currency impact | ( | ||
Loss on Blue Chip Swap transactions | ( | ( | ( |
Other, net | ( | ( | ( |
Income before income taxes | |||
Income tax provision | ( | ( | ( |
Net income | $ | $ | $ |
Net income attributable to noncontrolling interest | ( | ( | ( |
Net income attributable to company | $ | $ | $ |
Basic net income per share | $ | $ | $ |
Diluted net income per share | $ | $ | $ |
Basic weighted average common shares outstanding | |||
Diluted weighted average common shares outstanding | |||
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Net income | $ | $ | $ |
Other comprehensive income (loss), net of income taxes: | |||
Defined benefit and other post retirement plans adjustment | ( | ( | ( |
Other | |||
Other comprehensive loss, net of income taxes | ( | ( | ( |
Comprehensive income | $ | $ | $ |
Comprehensive income attributable to noncontrolling interest | ( | ( | ( |
Comprehensive income attributable to company shareholders | $ | $ | $ |
December 31, | ||
Millions of dollars and shares except per share data | 2025 | 2024 |
Assets | ||
Current assets: | ||
Cash and equivalents | $ | $ |
Receivables (net of allowances for credit losses of $805 and $754) | ||
Inventories | ||
Other current assets | ||
Total current assets | ||
Property, plant, and equipment (net of accumulated depreciation of $12,616 and $12,461) | ||
Goodwill | ||
Deferred income taxes | ||
Operating lease right-of-use assets | ||
Other assets | ||
Total assets | $ | $ |
Liabilities and Shareholders' Equity | ||
Current liabilities: | ||
Accounts payable | $ | $ |
Accrued employee compensation and benefits | ||
Income taxes payable | ||
Taxes other than income | ||
Current portion of operating lease liabilities | ||
Current maturities of long-term debt | ||
Other current liabilities | ||
Total current liabilities | ||
Long-term debt | ||
Operating lease liabilities | ||
Employee compensation and benefits | ||
Other liabilities | ||
Total liabilities | ||
Shareholders' equity: | ||
Common stock, par value $2.50 per share (authorized 2,000 shares, issued 1,064 and 1,065 shares) | ||
Paid-in capital in excess of par value | ||
Accumulated other comprehensive loss | ( | ( |
Retained earnings | ||
Treasury stock, at cost (229 and 197 shares) | ( | ( |
Company shareholders' equity | ||
Noncontrolling interest in consolidated subsidiaries | ||
Total shareholders' equity | ||
Total liabilities and shareholders' equity | $ | $ |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Cash flows from operating activities: | |||
Net income | $ | $ | $ |
Adjustments to reconcile net income to cash flows from operating activities: | |||
Depreciation, depletion, and amortization | |||
Impairments and other charges | |||
Deferred income tax provision | |||
Changes in assets and liabilities: | |||
Receivables | ( | ( | |
Inventories | ( | ||
Accounts payable | ( | ||
Other operating activities | ( | ||
Total cash flows provided by operating activities | |||
Cash flows from investing activities: | |||
Capital expenditures | ( | ( | ( |
Purchase of an equity investment | ( | ( | |
Purchase of investment securities | ( | ( | ( |
Payments to acquire businesses, net of cash acquired | ( | ( | ( |
Sales of investment securities | |||
Proceeds from sales of property, plant, and equipment | |||
Sale of an equity investment | |||
Other investing activities | ( | ( | ( |
Total cash flows used in investing activities | ( | ( | ( |
Cash flows from financing activities: | |||
Stock repurchase program | ( | ( | ( |
Dividends to shareholders | ( | ( | ( |
Payments on long-term borrowings | ( | ( | ( |
Proceeds from issuance of common stock | |||
Other financing activities | ( | ( | ( |
Total cash flows used in financing activities | ( | ( | ( |
Effect of exchange rate changes on cash | ( | ( | ( |
Increase (decrease) in cash and cash equivalents | ( | ( | |
Cash and equivalents at beginning of period | |||
Cash and equivalents at end of period | $ | $ | $ |
Supplemental disclosure of cash flow information: | |||
Cash payments during the period for: | |||
Interest | $ | $ | $ |
Income taxes | $ | $ | $ |
Company Shareholders’ Equity | |||||||
Millions of dollars | Common Stock | Paid-in Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interest in Consolidated Subsidiaries | Total |
Balance at December 31, 2022 | $ | $ | $( | $ | $( | $ | $ |
Comprehensive income (loss): | |||||||
Net income | |||||||
Other comprehensive loss | ( | ( | |||||
Cash dividends ($0.64 per share) | ( | ( | |||||
Stock plans | ( | ( | |||||
Stock repurchase program | ( | ( | |||||
Other | ( | ( | |||||
Balance at December 31, 2023 | $ | $ | $( | $ | $( | $ | $ |
Comprehensive income (loss): | |||||||
Net income | |||||||
Other comprehensive loss | ( | ( | |||||
Cash dividends ($0.68 per share) | ( | ( | |||||
Stock plans | ( | ( | |||||
Stock repurchase program | ( | ( | |||||
Other | ( | ( | |||||
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ |
Comprehensive income (loss): | |||||||
Net income | |||||||
Other comprehensive loss | ( | ( | |||||
Cash dividends ($0.68 per share) | ( | ( | |||||
Stock plans | ( | ||||||
Stock repurchase program | ( | ( | |||||
Other | ( | ( | |||||
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Item 8 | Notes to Consolidated Financial Statements |
Millions of dollars | Completion and Production | Drilling and Evaluation | Total |
Balance at December 31, 2023: | $ | $ | $ |
Current year acquisitions | |||
Other | ( | ( | |
Balance at December 31, 2024: | $ | $ | $ |
Current year acquisitions | |||
Other | |||
Balance at December 31, 2025: | $ | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Severance costs | $ | $ | $ |
Impairment of assets held for sale | |||
Fixed and Other assets write-offs | |||
Impairment of real estate facilities | |||
Equity in earnings loss | |||
Gain on investment | ( | ( | |
Cybersecurity incident | ( | ||
Other | |||
Total impairments and other charges | $ | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Revenue: | |||
Completion and Production | $ | $ | $ |
Drilling and Evaluation | |||
Total revenue | $ | $ | $ |
Operating income: | |||
Completion and Production | $ | $ | $ |
Drilling and Evaluation | |||
Total operations | |||
Corporate and other (a) | ( | ( | ( |
SAP S4 upgrade expense | ( | ( | ( |
Impairments and other charges (b) | ( | ( | |
Total operating income | $ | $ | $ |
Interest expense, net of interest income | $( | $( | $( |
Loss on Blue Chip Swap transactions | ( | ( | ( |
Argentina currency impact | ( | ||
Other, net (c) | ( | ( | ( |
Income before income taxes | $ | $ | $ |
Capital expenditures: | |||
Completion and Production | $ | $ | $ |
Drilling and Evaluation | |||
Corporate and other | |||
Total capital expenditures | $ | $ | $ |
Depreciation, depletion, and amortization: | |||
Completion and Production | $ | $ | $ |
Drilling and Evaluation | |||
Corporate and other | |||
Total depreciation, depletion, and amortization | $ | $ | $ |
(a) | Includes certain expenses not attributable to a business segment, such as costs related to support functions, corporate executives, and operating lease assets, and includes amortization expense associated with intangible assets recorded as a result of acquisitions. | ||
(b) | Impairments and other charges are as follows: –For the year ended December 31, 2025, amount includes approximately $ $ –For the year ended December 31, 2024, amount includes approximately $ $ | ||
(c) | During the year ended December 31, 2025, Halliburton incurred a charge of $23 million due to the impairment of an investment in Argentina. During the year ended December 31, 2024, Halliburton incurred a charge of $82 million primarily due to the impairment of an investment in Argentina and currency devaluation in Egypt. | ||
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | ||
2025 | ||
Millions of dollars | Completion and Production | Drilling and Evaluation |
Segment operating expenses: | ||
Cost of products, materials, and supplies | $ | $ |
Compensation | ||
Depreciation, depletion, and amortization | ||
Other | ||
Total segment operating expenses | $ | $ |
Year Ended December 31, | ||
2024 | ||
Millions of dollars | Completion and Production | Drilling and Evaluation |
Segment operating expenses: | ||
Cost of products, materials, and supplies | $ | $ |
Compensation | ||
Depreciation, depletion, and amortization | ||
Other | ||
Total segment operating expenses | $ | $ |
Year Ended December 31, | ||
2023 | ||
Millions of dollars | Completion and Production | Drilling and Evaluation |
Segment operating expenses: | ||
Cost of products, materials, and supplies | $ | $ |
Compensation | ||
Depreciation, depletion, and amortization | ||
Other | ||
Total segment operating expenses | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
December 31, | ||
Millions of dollars | 2025 | 2024 |
Total assets: | ||
Completion and Production (a) | $ | $ |
Drilling and Evaluation (a) | ||
Corporate and other (b) | ||
Total assets | $ | $ |
(a) | Assets associated with specific segments primarily include receivables, inventories, property, plant, and equipment, operating lease right-of- use assets, equity in and advances to related companies, and goodwill. | ||
(b) | Includes primarily cash and equivalents and deferred tax assets. | ||
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Revenue: | |||
North America | $ | $ | $ |
Latin America | |||
Europe/Africa/CIS | |||
Middle East/Asia | |||
Total revenue | $ | $ | $ |
December 31, | ||
Millions of dollars | 2025 | 2024 |
Net property, plant, and equipment: | ||
North America | $ | $ |
Latin America | ||
Europe/Africa/CIS | ||
Middle East/Asia | ||
Total net property, plant, and equipment | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Revenue by segment: | |||
Completion and Production | $ | $ | $ |
Drilling and Evaluation | |||
Total revenue | $ | $ | $ |
Revenue by geographic region: | |||
North America | $ | $ | $ |
Latin America | |||
Europe/Africa/CIS | |||
Middle East/Asia | |||
Total revenue | $ | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Millions of dollars | Balance at Beginning of Period | Provision (a) | Other (b) | Balance at End of Period (c) | |
Year ended December 31, 2023 | $ | $ | $( | $ | |
Year ended December 31, 2024 | ( | ||||
Year ended December 31, 2025 | ( | ||||
(a) | Represents increases to allowance for credit losses charged to costs and expenses, net of recoveries. | ||||
(b) | Includes write-offs and other activity. | ||||
(c) | The allowance for credit losses in all years is primarily comprised of a full reserve against accounts receivable with our primary customer in Venezuela. | ||||
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Components of lease expense: | |||
Finance lease cost: | |||
Amortization of right-of-use assets | $ | $ | $ |
Interest on lease liabilities | |||
Operating lease cost | |||
Short-term lease cost | |||
Sublease income | ( | ( | ( |
Total lease cost | $ | $ | $ |
December 31, | ||
Millions of dollars | 2025 | 2024 |
Components of balance sheet: | ||
Operating leases: | ||
Operating lease right-of-use assets (non-current) | $ | $ |
Current portion of operating lease liabilities | ||
Operating lease liabilities (non-current) | ||
Finance leases: | ||
Other assets (non-current) | $ | $ |
Other current liabilities | ||
Other liabilities (non-current) | ||
Year Ended December 31, | |||
Millions of dollars except years and percentages | 2025 | 2024 | 2023 |
Other supplemental information: | |||
Cash paid for amounts included in the measurement of lease liabilities: | |||
Operating cash flows for operating leases | $ | $ | $ |
Operating cash flows for finance leases | |||
Financing cash flows for finance leases | |||
Right-of-use assets obtained in exchange for lease obligations: | |||
Operating leases | $ | $ | $ |
Finance leases | |||
Weighted-average remaining lease term: | |||
Operating leases | |||
Finance leases | |||
Weighted-average discount rate for operating leases | |||
Item 8 | Notes to Consolidated Financial Statements |
Millions of dollars | Operating Leases | Finance Leases |
2026 | $ | $ |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total lease payments | ||
Imputed interest | ( | ( |
Total lease payments, net of imputed interest | $ | $ |
December 31, | ||
Millions of dollars | 2025 | 2024 |
Finished products and parts | $ | $ |
Raw materials and supplies | ||
Work in process | ||
Total inventories | $ | $ |
December 31, | ||
Millions of dollars | 2025 | 2024 |
Confirmed obligations outstanding at the beginning of the year | $ | $ |
Invoices added during the year | ||
Confirmed invoices paid during the year | ( | ( |
Confirmed obligations outstanding at the end of the year | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
December 31, | ||
Millions of Dollars | 2025 | 2024 |
Land | $ | $ |
Buildings and property improvements | ||
Machinery, equipment, and other | ||
Total property, plant, and equipment | ||
Accumulated depreciation | ( | ( |
Net property, plant, and equipment | $ | $ |
Buildings and Property Improvements | ||
2025 | 2024 | |
1 - 10 years | ||
11 - 20 years | ||
21 - 30 years | ||
31 - 40 years | ||
Machinery, Equipment, and Other | ||
2025 | 2024 | |
1 - 5 years | ||
6 - 10 years | ||
11 - 20 years | ||
December 31, | ||
Millions of dollars | 2025 | 2024 |
5.0% senior notes due November 2045 | $ | $ |
2.92% senior notes due March 2030 | ||
4.85% senior notes due November 2035 | ||
7.45% senior notes due September 2039 | ||
4.75% senior notes due August 2043 | ||
6.7% senior notes due September 2038 | ||
4.5% senior notes due November 2041 | ||
7.6% senior debentures due August 2096 | ||
6.75% senior notes due February 2027 | ||
Other | ||
Unamortized debt issuance costs and discounts | ( | ( |
Total long-term debt | $ | $ |
Short-term borrowings and current maturities of long-term debt | ||
Total debt | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
December 31, | ||
Millions of dollars | 2025 | 2024 |
4.75% senior notes due August 2043 | $ | $ |
4.5% senior notes due November 2041 | ||
5.0% senior notes due November 2045 | ||
7.45% senior notes due September 2039 | ||
4.85% senior notes due November 2035 | ||
7.6% senior debentures due August 2096 | ||
Total Repurchases | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Current income taxes: | |||
Federal | $( | $ | $( |
Foreign | ( | ( | ( |
State | ( | ( | ( |
Total current income taxes | ( | ( | ( |
Deferred income taxes: | |||
Federal | ( | ( | ( |
Foreign | ( | ||
State | ( | ( | |
Total deferred income taxes | ( | ( | ( |
Income tax provision | $( | $( | $( |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
United States | $ | $ | $ |
Foreign | |||
Total income from continuing operations before income taxes | $ | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | ||
Millions of dollars | 2025 | |
U.S. Federal Statutory Tax Rate | $ | |
State and Local Income Tax, Net of Federal Income Tax Effect (a) | ( | ( |
Foreign Tax Effects | ||
Argentina | ||
Intercompany Withholding Tax | ||
Other | ||
Brazil | ||
Cayman Islands | ||
Statutory Tax Rate Difference Between Cayman Islands and United States | ||
Mexico | ||
Foreign Exchange / Inflation Adjustment | ( | ( |
Other | ||
Norway | ||
Saudi Arabia | ||
Intercompany Withholding Tax | ||
Other | ( | ( |
Singapore | ||
Statutory Tax Rate Difference Between Singapore and United States | ( | ( |
Other | ||
United Arab Emirates | ( | ( |
Other Foreign Jurisdictions | ||
Domestic Federal Reconciling Items | ||
Effect of Cross-Border Tax Laws | ||
Foreign Derived Intangible Income Deduction | ( | ( |
Global Intangible Low-Taxed Income | ||
Other | ||
Tax Credits | ||
Foreign Tax Credit | ( | ( |
Research & Development Credit | ( | ( |
Changes in Valuation Allowances | ||
Nontaxable or Nondeductible items | ||
Other Adjustments | ( | ( |
Changes in Unrecognized Tax Benefits | ( | ( |
Effective Tax Rate | $ | |
(a) | During the year ended December 31, 2025, state and local income taxes in Texas comprise the majority (greater than 50 percent) of the state and local income taxes, net of federal effect category. | ||||
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | ||
2024 | 2023 | |
United States statutory rate | ||
Valuation allowance against tax assets | ( | |
Impact of foreign income taxed at different rates | ||
State income taxes | ||
Impact of impairments and other charges | ||
Adjustments of prior year taxes | ( | ( |
Other items, net | ( | ( |
Total effective tax rate on continuing operations | ||
December 31, | ||
Millions of dollars | 2025 | 2024 |
Gross deferred tax assets: | ||
Foreign tax credit carryforwards | $ | $ |
Intangible assets | ||
Operating and capital loss carryforwards | ||
Royalty prepayment | ||
Accrued liabilities | ||
Employee compensation and benefits | ||
Research and development tax credit carryforwards | ||
Other | ||
Total gross deferred tax assets | ||
Gross deferred tax liabilities: | ||
Depreciation and amortization | ||
Operating lease right-of-use assets | ||
Other | ||
Total gross deferred tax liabilities | ||
Valuation allowances | ||
Net deferred income tax asset | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Millions of dollars | U.S. Net Operating Loss | Foreign Operating and Capital Loss | Foreign Tax Credits | Research and Development Credit | Total Deferred Tax Assets |
2026-2030 | $ | $ | $ | $ | $ |
2031-2035 | |||||
2036-2045 | |||||
Non-Expiring | |||||
$ | $ | $ | $ | $ |
Millions of dollars | Unrecognized Tax Benefits | Interest and Penalties | |
Balance at January 1, 2023 | $ | $ | |
Change in prior year tax positions | ( | ( | |
Change in current year tax positions | |||
Cash settlements with taxing authorities | ( | ( | |
Lapse of statute of limitations | ( | ( | |
Balance at December 31, 2023 | $ | (a) | $ |
Change in prior year tax positions | ( | ||
Change in current year tax positions | |||
Cash settlements with taxing authorities | ( | ( | |
Lapse of statute of limitations | ( | ( | |
Balance at December 31, 2024 | $ | (a) | $ |
Change in prior year tax positions | |||
Change in current year tax positions | |||
Cash settlements with taxing authorities | ( | ||
Lapse of statute of limitations | ( | ( | |
Balance at December 31, 2025 | $ | (a)(b) | $ |
(a) | Includes $ unrecognized tax benefits that would give rise to a United States tax credit. As of December 31, 2025, December 31, 2024, and December 31, 2023, a net $ unrecognized tax benefits would positively impact the effective tax rate and be recognized as additional tax benefits in our statement of operations if resolved in our favor. |
(b) | Includes $ |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |
Million of dollars | 2025 |
US Federal | $ |
US State and Local | |
Foreign | |
Mexico | |
Saudi Arabia | |
Other | |
Foreign Subtotal | |
Total | $ |
Item 8 | Notes to Consolidated Financial Statements |
December 31, | ||
Millions of shares | 2025 | 2024 |
Issued | ||
In treasury | ( | ( |
Total shares of common stock outstanding | ||
December 31, | ||
Millions of dollars | 2025 | 2024 |
Cumulative translation adjustments | $( | $( |
Defined benefit and other postretirement liability adjustments (a) | ( | ( |
Other | ( | ( |
Total accumulated other comprehensive loss | $( | $( |
(a) | Included net actuarial losses for our international pension plans of $ December 31, 2024. | ||
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of dollars | 2025 | 2024 | 2023 |
Stock-based compensation cost | $ | $ | $ |
Tax benefit | ( | ( | ( |
Stock-based compensation cost, net of tax | $ | $ | $ |
Number of Shares (in millions) | Weighted Average Exercise Price per Share | Weighted Average Remaining Contractual Term (years) | Aggregate Intrinsic Value (in millions) | |
Outstanding at January 1, 2025 | $ | |||
Exercised | ||||
Forfeited/expired | ( | |||
Outstanding at December 31, 2025 | $ | $ | ||
Exercisable at December 31, 2025 | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Number of Shares (in millions) | Weighted Average Grant-Date Fair Value per Share | |
Nonvested shares at January 1, 2025 | $ | |
Granted | ||
Vested | ( | |
Forfeited | ( | |
Nonvested shares at December 31, 2025 | $ |
Year Ended December 31, | |||
2025 | 2024 | 2023 | |
Expected volatility | |||
Expected dividend yield | |||
Risk-free interest rate | |||
Weighted average grant-date fair value per share | $ | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
Year Ended December 31, | |||
Millions of shares | 2025 | 2024 | 2023 |
Basic weighted average common shares outstanding | |||
Dilutive effect of awards granted under our stock incentive plans | |||
Diluted weighted average common shares outstanding | |||
Antidilutive shares: | |||
Weighted average options with exercise price greater than the average market price | |||
Total antidilutive shares | |||
December 31, 2025 | December 31, 2024 | ||||||||
Millions of dollars | Level 1 | Level 2 | Total fair value | Carrying value | Level 1 | Level 2 | Total fair value | Carrying value | |
Total debt | $ | $ | $ | $ | $ | $ | $ | $ | |
Item 8 | Notes to Consolidated Financial Statements |
Item 8 | Notes to Consolidated Financial Statements |
December 31, | ||
Millions of dollars | 2025 | 2024 |
Amounts recognized on the Consolidated Balance Sheets | ||
Other assets | $ | $ |
Accrued employee compensation and benefits | ||
Employee compensation and benefits | ||
Pension plans in which projected benefit obligation exceeded plan assets | ||
Projected benefit obligation | $ | $ |
Fair value of plan assets | ||
Pension plans in which accumulated benefit obligation exceeded plan assets | ||
Accumulated benefit obligation | $ | $ |
Fair value of plan assets | ||
Item 8 | Notes to Consolidated Financial Statements |
Millions of dollars | Level 1 | Level 2 | Level 3 | Net Asset Value (a) | Total |
Cash and equivalents | $ | $ | $ | $ | $ |
Bond funds (b) | |||||
Real estate funds (c) | |||||
Other investments (d) | |||||
Fair value of plan assets at December 31, 2025 | $ | $ | $ | $ | $ |
Cash and equivalents | $ | $ | $ | $ | $ |
Bond funds (b) | |||||
Real estate funds (c) | |||||
Other investments (d) | |||||
Fair value of plan assets at December 31, 2024 | $ | $ | $ | $ | $ |
(a) | Represents investments measured at fair value using the Net Asset Value (NAV) per share practical expedient and thus has not been categorized in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total value of our international pension plan assets. | ||||
(b) | Strategy of bond funds is to invest in diversified funds of fixed income securities of varying geographies and credit quality. | ||||
(c) | Strategy of real estate funds is to invest in diversified funds of real estate investment trusts and private real estate. | ||||
(d) | Other investments consist of insurance contracts, a buy-in annuity insurance contract, non-US equities, and government bonds. The fair value of the buy-in annuity insurance contract is determined using a quote provided by an insurance company, reflecting prevailing market conditions for similar transactions. | ||||
Millions of dollars | 2025 | 2024 |
Balance at the beginning of the year | $ | $ |
Purchase of insurance contract | ||
Return on assets | ( | |
Payment from the insurance policy | ( | ( |
Balance at the end of the year | $ | $ |
Item 8 | Notes to Consolidated Financial Statements |
2025 | 2024 | |
Discount rate | ||
Rate of compensation increase |
2025 | 2024 | 2023 | |
Discount rate | |||
Expected long-term return on plan assets | |||
Rate of compensation increase |
Item 9 | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
Item 10 | Directors, Executive Officers and Corporate Governance |
Item 14 | Principal Accounting Fees and Services |
(a) | List of documents filed as part of this Annual Report. | |
(1) | Financial Statements: | |
The reports of the Independent Registered Public Accounting Firm and the financial statements of Halliburton Company are included within Part II, Item 8 of this Annual Report on Form 10-K. | ||
(2) | Financial Statement Schedules: | |
The schedules listed in Rule 5-04 of Regulation S-X (17 CFR 210.5-04) have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto. | ||
(3) | Exhibits: | |
See exhibits listed under Part (b) below. | ||
4.6 | ||
4.7 | Copies of instruments that define the rights of holders of miscellaneous long-term notes of Halliburton Company and its subsidiaries have not been filed with the Commission. Halliburton Company agrees to furnish copies of these instruments upon request. | |
4.8 | Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser’s Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, | |
4.9 | Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated | |
4.10 | ||
4.11 | ||
4.12 | ||
4.13 | ||
4.14 | ||
4.15 | ||
4.16 | ||
4.17 | ||
4.18 | ||
4.19 | ||
4.20 | ||
4.21 | ||
4.22 | ||
4.23 | ||
4.24 | ||
4.25 | ||
4.26 | ||
4.27 | ||
4.28 | ||
4.29 | ||
4.30 | ||
† | 10.1 | |
† | 10.2 | |
† | 10.3 | |
† | 10.4 | |
† | 10.5 | |
† | 10.6 | |
† | 10.7 | |
† | 10.8 | |
† | 10.9 | |
† | 10.10 | |
† | 10.11 | |
† | 10.12 | |
† | 10.13 | |
† | 10.14 | |
† | 10.15 | |
† | 10.16 | |
† | 10.17 | |
† | 10.18 | |
† | 10.19 | |
10.20 | ||
† | 10.21 | |
† | 10.22 | |
† | 10.23 | |
† | 10.24 | |
† | 10.25 | |
† | 10.26 | |
† | 10.27 | |
† | 10.28 | |
10.29 | ||
10.30 | ||
† | 10.31 | |
† | 10.32 | |
† | 10.33 | |
† | 10.34 | |
† | 10.35 | |
† | 10.36 | |
† | 10.37 | |
† | 10.38 | |
† | 10.39 | |
*† | 10.40 | |
*† | 10.41 | |
*† | 10.42 | |
*† | 10.43 | |
*† | 10.44 | |
19.1 | ||
19.2 | ||
* | 21.1 | |
* | 23.1 | |
* | 31.1 | |
* | 31.2 | |
** | 32.1 | |
** | 32.2 | |
* | 95 | |
97.1 | ||
* | 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
* | 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
* | 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
* | 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
* | 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
* | 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
* | 104 | Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
* Filed with this Form 10-K. | ||
** Furnished with this Form 10-K. | ||
† Management contracts or compensatory plans or arrangements. | ||
HALLIBURTON COMPANY | |
By | /s/ Jeffrey A. Miller |
Jeffrey A. Miller | |
Chairman of the Board, President and Chief Executive Officer |
Signature | Title |
/s/ Jeffrey A. Miller | Chairman of the Board, Director, President and |
Jeffrey A. Miller | Chief Executive Officer |
/s/ Eric J. Carre | Executive Vice President and |
Eric J. Carre | Chief Financial Officer |
/s/ Stephanie S. Holzhauser | Senior Vice President and |
Stephanie S. Holzhauser | Chief Accounting Officer |
Signature | Title |
/s/ Abdulaziz F. Al Khayyal | Director |
Abdulaziz F. Al Khayyal | |
/s/ William E. Albrecht | Director |
William E. Albrecht | |
/s/ M. Katherine Banks | Director |
M. Katherine Banks | |
/s/ Alan M. Bennett | Director |
Alan M. Bennett | |
/s/ Earl M. Cummings | Director |
Earl M. Cummings | |
/s/ Murry S. Gerber | Director |
Murry S. Gerber | |
/s/ Timothy A. Leach | Director |
Timothy A. Leach | |
/s/ Robert A. Malone | Director |
Robert A. Malone | |
/s/ J. Shannon Slocum | Director |
J. Shannon Slocum | |
/s/ Maurice S. Smith | Director |
Maurice S. Smith | |
/s/ Janet L. Weiss | Director |
Janet L. Weiss | |
/s/ Tobi M. Edwards Young | Director |
Tobi M. Edwards Young | |